Empagliflozin AttenuatesHFD/STZ-induced
Liver Fibrosis in Type 2 Diabetes Mellitus Mice by Modulating Gut
Microbiota
Running title: Novel Therapeutic Effects of Empagliflozin
Chuxin Huang1*, Jiali Qian1*, Ying
Liu1*, Li Zhang1#, Yehong
Yang1#
1 Department of Endocrinology, Huashan Hospital, Fudan
University, Shanghai 200040, P.R. China
* These authors contributed equally to this work
# Corresponding authors: Huashan Hospital, Fudan
University, 12 Middle Wulumuqi Road, Shanghai 200040, P.R. China
E-mail: yehongyang@fudan.edu.cn
(Y.Yang)/lenzhangli@hotmail.com (L.Zhang)
Telephone number: +86-21-52887820; Fax: +86-21-52887820